CD200 and B-cell chronic lymphocytic leukemia: Sustained decreases in CD200 expression on peripheral CD200+ CD4+ T cells (reduction in the percentage of CD200+ CD4+ T cells) is observed in CLL and MM patients at higher doses (300–600 mg/m2).